David J. McCann

Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population

Deborah S. Hasin, Melanie M. Wall, Katie Witkiewitz et al. · The Lancet Psychiatry · 2017 · 139 citations

Substance Abuse, Alcohol Misuse, Substance Use +12

Mitigating the Effects of Nonadherence in Clinical Trials

Thomas Shiovitz, Earle Bain, David J. McCann et al. · The Journal of Clinical Pharmacology · 2015 · 115 citations · Full text

Non-pharmacological Intervention, Meta-analysis, Clinical Effectiveness +11

<i>Sigma</i>‐1 and <i>Sigma</i>‐2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns

David J. McCann, Arthur D. Weissman, Tsung‐Ping Su · Synapse · 1994 · 113 citations

Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (σ sites) exhibit a unique distribution in rat brain subcellular fractions

David J. McCann, Tsung‐Ping Su · European Journal of Pharmacology Molecular Pharmacology · 1990 · 73 citations

Synaptic Signaling, Neurophysiology, Synaptic Transmission +9

Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.

David J. McCann, Tsung‐Ping Su · Journal of Pharmacology and Experimental Therapeutics · 1991 · 67 citations